This morning AI-enabled symptom checker Infermedica revealed exclusively to MobiHealthNews a new $3.65 million funding round. Estonian investor Karma Ventures led the round with participation from Dreamit Ventures, Inovo Venture Partners and Müller Medien.
Originally founded in Poland, the company has recently expanded its international footprint with a move into the United States.
WHAT THEY...
